SOURCE: Solos Endoscopy, Inc.

June 13, 2006 08:30 ET

Solos Endoscopy, Inc. Retains Regulatory Consulting Firm for New Product Strategy

BOSTON, MA -- (MARKET WIRE) -- June 13, 2006 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSE) is pleased to announce that they have retained the services of Lynette Howard of Lyle Howard Corporation to review Solos Endoscopy's current filings with the Food and Drug Administration. She will assist in the implementation of a new quality management process for the Company.

Solos Endoscopy has a number of new products in development and will look to Ms. Howard to advise the Company on the regulatory clearance process and quality assurance methods. Ms. Howard will also oversee the certification for all Solos products sold outside the Unites States.

Lynette Howard received her Bachelors of Science from Clarkson University, in New York and has also received Association of Advancement of Medical Instrumentation and European Diagnostic Manufacturers Association certifications. Ms. Howard was formerly a supervisor and Sr. Analyst for Ethicon, Inc., a Johnson & Johnson company.

"We are very pleased to have Ms. Howard overseeing our regulatory and quality management systems. Solos Endoscopy has always maintained a superior quality management system and will look to maintain this standard as we move into the future. The Company has a number of new products in the pipeline and we are fortunate to have Ms. Howard to assure Solos' compliance with all FDA policies and procedures," stated Robert Segersten, President of Solos Endoscopy, Inc.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office Additional information is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information

  • Contact:
    Big Apple Consulting USA, Inc. for Solos Endoscopy, Inc.
    Investor Relations
    407-884-0444 or 1-866-THE-APPL(E)